old ALS News Today Home
Recent Posts
- Enrollment Resumes in Masitinib Trials at Some European Sites
- Out of ‘Stealth’ Mode, QurAlis Expects First QRL-201 Trial in 2022
- Two Tests May Be Better Than One at Predicting Survival
- Just Another Day in Life With ALS
- Phase 1b Trial of Oral DNL343 in ALS Patients Begins Dosing
- Awaiting the ‘Hope Begets Hope’ Aria
- Amylyx Plans to File for Approval of AMX0035 in US
- New Institute Aims to Leave No Rare Disease Patient Behind
- Planning and Preparing Help Me Live With ALS
- Clene Soon Will Complete Phase 2 Trial Testing CNM-Au8